Daniel G. Coit, Robert Andtbacka, Christopher K. Bichakjian, Raza A. Dilawari, Dominick DiMaio, Valerie Guild, Allan C. Halpern, F. Stephen Hodi, Mohammed Kashani-Sabet, Julie R. Lange, Anne Lind, Lainie Martin, Mary C. Martini, Scott K. Pruitt, Merrick I. Ross, Stephen F. Sener, Susan M. Swetter, Kenneth K. Tanabe, John A. Thompson, Vijay TrisalMarshall M. Urist, Jeffrey Weber, Michael K. Wong

Research output: Contribution to journalArticlepeer-review

134 Scopus citations


These guidelines represent an effort to distill and simplify an enormous body of knowledge and experience into fairly simple management algorithms. In general, treatment recommendations for primary tumors are based on better data than the recommendations for treating recurrent disease. Few, if any, firm recommendations can be made about more controversial issues for melanoma patients, such as the extent of workup or intensity of follow-up. These guidelines are intended as a point of departure, recognizing that all clinical decisions about individual patient management must be tempered by the clinician's judgment and other factors, such as local resources and expertise, and the individual patient's needs, wishes, and expectations. Furthermore, these guidelines are revised annually and continually as new data become available.

Original languageEnglish (US)
Pages (from-to)250-275
Number of pages26
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number3
StatePublished - Mar 2009


  • Adjuvant therapy
  • Biopsy
  • Chemotherapy
  • Interferon
  • Lymph node dissection
  • Margin
  • Melanoma
  • Metastases
  • NCCN Clinical Practice Guidelines
  • Pathology
  • Radiation therapy
  • Sentinel lymph node
  • Skin cancer
  • Surgical excision

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Melanoma'. Together they form a unique fingerprint.

Cite this